Chronic Obstructive Pulmonary Disease heterogeneity: Challenges for health risk assessment, stratification and management

Journal of Translational Medicine

Volumn 12, Issue , 2014, Pages

  Roca, Josep ^a,b   Vargas, Claudia ^a   Cano, Isaac ^a   Selivanov, Vitaly ^a   Barreiro, Esther ^b,c   Maier, Dieter ^d   Falciani, Francesco ^e   Wagner, Peter ^f   Cascante, Marta ^a,b,g   Garcia Aymerich, Judith ^c   Kalko, Susana ^a   De Mas, Igor Marin ^a   Tegnér, Jesper ^h   Escarrabill, Joan ^a,b   Alvar Agusti ^a,b   Gomez Cabrero, David ^h  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d Biomax Informatics AG   (Germany)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF BARCELONA   (Spain)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; HEALTH HAZARD; HUMAN; MUSCLE ATROPHY; MUSCLE DISEASE; OUTCOME ASSESSMENT; REVIEW; RISK ASSESSMENT; SKELETAL MUSCLE; SKELETAL MUSCLE DYSFUNCTION; BLOOD; CHEMISTRY; CLUSTER ANALYSIS; DECISION SUPPORT SYSTEM; GENE EXPRESSION PROFILING; LUNG DISEASE; LUNG INJURY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

CYTOKINE; OXYGEN;

CLUSTER ANALYSIS; COMORBIDITY; CYTOKINES; DECISION SUPPORT SYSTEMS, CLINICAL; GENE EXPRESSION PROFILING; HUMANS; LUNG DISEASES; LUNG INJURY; MUSCLE, SKELETAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXYGEN; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84930691275     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-S2-S3     Document Type: Review

References (50)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American journal of respiratory and critical care medicine 2013, 187:347-365.
2. Murray CJL, Lopez AD: Measuring the Global Burden of Disease. New England Journal of Medicine 2013, 369:448-457.
3. WHO: 2008-2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. ISBN: 9789241597418 2008 [http://www.who.int/nmh/publications/9789241597418/en/], Accessed: 2013-08-20. (Archived by WebCite® at http://www.webcitation.org/6J0XGnHcJ.
4. Agusti A, Calverley P, Celli B, Coxson H, Edwards L, Lomas D, MacNee W, Miller B, Rennard S, Silverman E: Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respiratory Research 2010, 11:122.
5. Casanova C, de Torres JP, Aguirre-Jaime A, Pinto-Plata V, Marin JM, Cordoba E, Baz R, Cote C, Celli BR: The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. American journal of respiratory and critical care medicine 2011, 184:1015-1021.
6. Vestbo J, Agusti A, Wouters EF, Bakke P, Calverley PM, Celli B, Coxson H, Crim C, Edwards LD, Locantore N, Lomas DA, MacNee W, Miller B, Rennard SI, Silverman EK, Yates JC, Tal-Singer R, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Study Investigators: Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. American journal of respiratory and critical care medicine 2014, 189:1022-1030.
7. Soler-Cataluna JJ, Rodriguez-Roisin R: Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious? Copd 2010, 7:276-284.
8. Hurst J, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas D, Agusti A, Macnee W: Susceptibility to exacerbation in chronic obstructive pulmonary disease. The New England journal of medicine 2010, 363:1128-1138.
9. Suissa S, Dell'Aniello S, Ernst P: Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012, 67:957-963.
10. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigare R, Dekhuijzen PN, Franssen F, Gayan-Ramirez G, Gea J, Gosker HR, Gosselink R, Hayot M, Hussain SN, Janssens W, Polkey MI, Roca J, Saey D, Schols AM, Spruit MA, Steiner M, Taivassalo T, Troosters T, Vogiatzis I, Wagner PD, ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD: An official american thoracic society/european respiratory society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 2014, 189: e15-62.
11. Miller J, Edwards LD, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Vestbo J, Wouters E, Yates JC, MacNee W, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators.: Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respiratory medicine 2013, 107:1376-1384.
12. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM: Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 2013, 187:728-735.
13. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B: Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine 2012, 186:155-161.
14. Fabbri LM, Beghe B, Agusti A: COPD and the solar system: introducing the chronic obstructive pulmonary disease comorbidome. American journal of respiratory and critical care medicine 2012, 186:117-119.
15. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American journal of respiratory and critical care medicine 2007, 176:532-555.
16. Calverley PMA: The ABCD of GOLD made clear. European Respiratory Journal 2013, 42:1163-1165.
17. Vogelmeier C, Vestbo J: COPD assessment: I, II, III, IV and/or A, B, C, D. European Respiratory Journal 2014, 43:949-950.
18. Celli B, Cote C, Marin J, Casanova C, Montes De Oca M, Mendez R, Pinto Plata V, Cabral H: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. The New England journal of medicine 2004, 350:1005-1012.
19. Puhan Ma, Garcia-Aymerich J, Frey M, ter Riet G, Antó JM, Agustí AG, Gómez FP, Rodríguez-Roisín R, Moons KG, Kessels AG: Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. The Lancet 2009, 374:704-711.
20. Puhan MA, Hansel NN, Sobradillo P, Enright P, Lange P, Hickson D, Menezes AM, Riet Gt, Held U, Domingo-Salvany A, Mosenifar Z, Antó JM, Moons KG, Kessels A, Garcia-Aymerich J, International COPD Cohorts Collaboration Working Group: Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts. BMJ Open 2012, 2.
21. Jones RC, Donaldson GC, Chavannes NH, Kida K, Dickson-Spillmann M, Harding S, Wedzicha JA, Price D, Hyland ME: Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. American journal of respiratory and critical care medicine 2009, 180:1189-1195.
22. Motegi T, Jones RC, Ishii T, Hattori K, Kusunoki Y, Furutate R, Yamada K, Gemma A, Kida K: A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations. International journal of chronic obstructive pulmonary disease 2013, 8:259-271.
23. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, Silverman EK, Tal-Singer E, ECLIPSE investigators: Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). The European respiratory journal 2008, 31:869-873.
24. Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R: Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clinical & Experimental Allergy 2005, 35:1254-1262.
25. Dustin ML: Signaling at neuro/immune synapses. Journal of Clinical Investigation 2012, 122:1149-1155.
26. Poole DC, Hirai DM, Copp SW, Musch TI: Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance. American journal of physiology Heart and circulatory physiology 2012, 302: H1050-1063.
27. Rodriguez DA GA-V, Diaz-Moralli S, Reed M, Gomez FP, Falciani F, Günther U, Roca J, Cascante M: Plasma metabolic profile in COPD patients: effects of exercise and endurance training. Metabolomics 2012, 8:508-516.
28. Rodriguez DA, Kalko S, Puig-Vilanova E, Perez-Olabarria M, Falciani F, Gea J, Cascante M, Barreiro E, Roca J: Muscle and blood redox status after exercise training in severe COPD patients. Free radical biology & medicine 2012, 52:88-94.
29. Gomez-Cabrero D L-AM, Tegner J, Cascante M, Miralles F, Roca J, the Synergy-COPD consortium: Synergy-COPD: A systems approach for understanding and managing Chronic Diseases. BMC Journal of Translational Medicine 2014.
30. Barnes PJ, Celli BR: Systemic manifestations and comorbidities of COPD. European Respiratory Jornal 2009, 33:1165-1185.
31. Gomez-Cabrero D MJ, Cano I, Abugessaisa I, Huertas-Migueláñez M, Tenyi A, Marin de Mas I, Kiani N, Marabita F, Falciani F, Burrowes K, Maier D, Wagner P, Selivanov V, Cascante M, Roca J, Barabási A, Tegnér J: Systems Medicine: from molecular features and models to the clinic in COPD. Journal of Translational Medicine 2014, 12(Suppl 2):S4.
32. Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R, Roca J, Barbera JA: Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. American journal of respiratory and critical care medicine 2010, 181:270-278.
33. Turan N, Kalko S, Stincone A, Clarke K, Sabah A, Howlett K, Curnow SJ, Rodriguez DA, Cascante M, O'Neill L, Egginton S, Roca J, Falciani F: A Systems Biology Approach Identifies Molecular Networks Defining Skeletal Muscle Abnormalities in Chronic Obstructive Pulmonary Disease. PLoS Comput Biol 2011, 7:e1002129.
34. Handy DE, Loscalzo J, Leopold JA: Systems analysis of oxidant stress in the vasculature. IUBMB life 2013, 65:911-920.
35. Zhou X, Menche J, Barabasi AL, Sharma A: Human symptoms-disease network. Nature communications 2014, 5:4212.
36. Barabasi AL: Network medicine-from obesity to the "diseasome". The New England journal of medicine 2007, 357:404-407.
37. Barabasi AL, Gulbahce N, Loscalzo J: Network medicine: a network-based approach to human disease. Nat Rev Genet 2011, 12:56-68.
38. Lee DS, Park J, Kay KA, Christakis NA, Oltvai ZN, Barabasi AL: The implications of human metabolic network topology for disease comorbidity. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:9880-9885.
39. Garcia-Aymerich J, Gomez FP, Benet M, Farrero E, Basagana X, Gayete A, Pare C, Freixa X, Ferrer J, Ferrer A, et al: Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011, 66:430-437.
40. Burrowes Kelly S DT, Brightling C: Computational modeling of the obstructive lung diseases asthma and COPD. Journal of Translational Medicine 2014, 12(Suppl 2):S5.
41. NEXES: Supporting Healthier and Independent Living for Chronic Patients and Elderly.2008-2013, CIP-ICT-PSP-225025.
42. Velickovski FCL, Roca J, Burgos F, Galdiz J, Nueria M, Lluch Ariet M: Clinical Decision Support Systems (CDSS) for preventive management of COPD patients. Journal of Translational Medicine 2014, 12(Suppl 2):S9.
43. Cano ITA, Schueller CH, Wolff M, Huertas M, Gomez-Cabrero D, Antczak PH, Roca J, Cascante M, Falciani F, Maier D: The COPD Knowledge Base: enabling data analysis and computational simulation in translational COPD research. Journal of Translational Medicine 2014, 12(Suppl 2):S6.
44. Barreiro E, Rabinovich R, Marin-Corral J, Barberà JA, Gea J, Roca J: Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax 2009, 64:13-19.
45. Rabinovich R, Bastos R, Ardite E, Llinàs L, Orozco-Levi M, Gea J, Vilaró J, Barberà Ja, Rodríguez-Roisin R, Fernández-Checa JC, Roca J: Mitochondrial dysfunction in COPD patients with low body mass index. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology 2007, 29:643-650.
46. van den Borst B, Slot IG, Hellwig VA, Vosse BA, Kelders MC, Barreiro E, Schols AM, Gosker HR: Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD. Journal of applied physiology 2013, 114:1319-1328, (Bethesda, Md: 1985).
47. Burgos F, Disdier C, de Santamaria EL, Galdiz B, Roger N, Rivera ML, Hervas R, Duran-Tauleria E, Garcia-Aymerich J, Roca J: Telemedicine enhances quality of forced spirometry in primary care. European Respiratory Journal 2012, 39:1313-1318.
48. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J: Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. The European respiratory journal 2012, 40:1324-1343.
49. Barberan-Garcia A, Vogiatzis I, Solberg HS, Vilaro J, Rodriguez DA, Garasen HM, Troosters T, Garcia-Aymerich J, Roca J: Effects and barriers to deployment of telehealth wellness programs for chronic patients across 3 European countries. Respiratory medicine 2014, 108:628-637.
50. Cano I L-AM, Gomez-Cabrero D, Maier D, Kalko S, Cascante M, Tégner J, Miralles F, Herrera D, Roca J, the Synergy COPD consortium: Biomedical Research in a Digital Health Framework. Journal of Translational Medicine 2014, 12(Suppl 2):S10.